Sökning: id:"swepub:oai:DiVA.org:uu-317040" >
Pharmacometrics Mod...
Pharmacometrics Modelling in Type 2 Diabetes Mellitus : Implications on Study Design and Diabetes Disease Progression
-
- Ghadzi, Siti Maisharah Sheikh (författare)
- Uppsala universitet,Institutionen för farmaceutisk biovetenskap,Pharmacometrics
-
- Kjellsson, Maria C., Associate Professor (preses)
- Uppsala universitet,Institutionen för farmaceutisk biovetenskap
-
- Karlsson, Mats O., Professor (preses)
- Uppsala universitet,Institutionen för farmaceutisk biovetenskap
-
visa fler...
-
- Visser, Sandra, PhD (opponent)
- Early Stage Quantitative Pharmacology & Pharmacometrics, Merck, USA
-
visa färre...
-
(creator_code:org_t)
- ISBN 9789155498443
- Uppsala : Acta Universitatis Upsaliensis, 2017
- Engelska 93 s.
-
Serie: Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy, 1651-6192 ; 226
- Relaterad länk:
-
https://uu.diva-port... (primary) (Raw object)
-
visa fler...
-
https://uu.diva-port... (Preview)
-
https://urn.kb.se/re...
-
visa färre...
Abstract
Ämnesord
Stäng
- Pharmacometric modelling is widely used in many aspects related to type 2 diabetes mellitus (T2DM), for instance in the anti-diabetes drug development, and in quantifying the disease progression of T2DM.The aim of this thesis were to improve the design of early phase anti-diabetes drug development studies with the focus on the power to identify mechanism of drug action (MoA), and to characterize and quantify the progression from prediabetes to overt diabetes, both the natural progression and the progression with diet and exercise interventions, using pharmacometrics modelling.The appropriateness of a study design depends on the MoAs of the anti-hyperglycaemic drug. Depending on if the focus is power to identify drug effect or accuracy and precision of drug effect, the best design will be different. Using insulin measurements on top of glucose has increase the power to identify a correct drug effect, distinguish a correct MoA from the incorrect, and to identify a secondary MoA in most cases. The accuracy and precision of drug parameter estimates, however, was not affected by insulin. A natural diabetes disease progression model was successfully added in a previously developed model to describe parameter changes of glucose and insulin regulation among impaired glucose tolerance (IGT) subjects, with the quantification of the lifestyle intervention. In this model, the assessment of multiple short-term provocations was combined to predict the long-term disease progression, and offers apart from the assessment of the onset of T2DM also the framework for how to perform similar analysis. Another previously published model was further developed to characterize the weight change in driving the changes in glucose homeostasis in subjects with IGT. This model includes the complex relationship between dropout from study and weight and glucose changes.This thesis has provided a first written guidance in designing a study for pharmacometrics analysis when characterizing drug effects, for early phase anti-diabetes drug development. The characterisation of the progression from prediabetes to overt diabetes using pharmacometrics modelling was successfully performed. Both the natural progression and the progression with diet and exercise interventions were quantified in this thesis.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Farmaceutiska vetenskaper (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Pharmaceutical Sciences (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Endokrinologi och diabetes (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Endocrinology and Diabetes (hsv//eng)
Nyckelord
- Pharmacometric
- type 2 diabetes mellitus
- impaired glucose tolerance
- prediabetes
- anti-diabetes drug development
- insulin
- glucose
- natural diabetes disease progression
- lifestyle intervention
- short-term provocation
- long-term effect
- glucose homeostasis
- glucose and insulin regulation
- weight
- dropout
- Pharmaceutical Science
- Farmaceutisk vetenskap
- Endokrinologi och Diabetologi
- Endocrinology and Diabetology
Publikations- och innehållstyp
- vet (ämneskategori)
- dok (ämneskategori)
Hitta via bibliotek
Till lärosätets databas